期刊文献+

淋巴系统肿瘤发病与EB病毒和IL-10基因多态性的关系 被引量:6

Association of Lymphoid Malignancy Incidence with EB Virus and IL-10 Gene Polymorphism——Review
下载PDF
导出
摘要 淋巴系统肿瘤与病毒感染有密切关系,EBV(Epstein-Barr Virus)转染正常B细胞会造成B细胞发生类似肿瘤的永生化,是最可疑的致病因素。EBV的Bcrf1编码框又称为病毒IL-10,和人类IL-10同源,具有和IL-10相似的免疫抑制作用。IL-10是一种重要的免疫调节因子,其分泌水平的高低影响着淋巴系统疾病的发生和发展;IL-10启动子区的SNP位点基因型也与IL-10的分泌水平相关。本综述探讨淋巴系统肿瘤,EBV感染以及IL-10基因多态性之间的密切关系。 EBV(Epstein-Barr Virus) is a common herpes virus in patient with lymphatic system tumor,which firstly discovered in the cell line of Burkitt′s lymphoma.90% people worldwide had been infected by EB virus before grown-up,but not all people have the EBV-related disease or tumor.Most EBV infection can not elicit clinical symptoms.EBV infection in tumor of lymphatic system is common.It was early known that the EBV existence may cause the immortalization of normal B cells,which like the tumor cells.It means that EBV plays an important role in the tumorigenesis.EBV Bcrf1 code frame is homology to human IL-10,which is also called viral IL-10,showing immunosuppressive effect similar to the IL-10.IL-10 is also an important immunoregulatory factor,the secretory level of which influences the occurrence and development of lymphatic system deseases;the genotype of SNP site in IL-10 promoter region also associates with secretory level of IL-10.This review disccuses the close relation between tumor of lymphatic system,EBV infection and gene polymorphison of IL-10.
出处 《中国实验血液学杂志》 CAS CSCD 2011年第2期528-531,共4页 Journal of Experimental Hematology
基金 科技部国际科技合作重大项目(编号2006DFB31430) 863高科技项目(编号2008AA062503)
关键词 淋巴系统肿瘤 IL-10 单核苷酸多态性 EB病毒 IL-10 SNP EBV Lymphoid malignancy
  • 相关文献

参考文献30

  • 1Iwakiri D, Takada K. Role of EBERs in the pathogenesis of EBV infection. Adv Cancer Res, 2010; 107 : 119 - 136.
  • 2Samanta M, Takada K. Modulation of innate immunity system by Epstein-Barr virus-encoded non-coding RNA and oncogenesis. Cancer Sci, 2010;101(!) :29 -35.
  • 3Harabuchi Y, Takahara M, Kishibe K, et al. Nasal natural killer (NK)/T-ceU lymphoma: clinical, histological, virological, and genetic features. Int J Clin Oncol, 2009;14(3) :181 - 190.
  • 4Samanta M, Iwakifi D, Takada K. Epstein-Barr virus-encoded small RNA induces IL-10 through RIG-I-mediated IRF-3 signaling. Oncogene, 2008 ;27 (30) :4150 - 4160.
  • 5Davis JM 3rd, Knutson KL, Strausbauch M_A, et al. Analysis of complex biornarkers for human immune-mediated disorders based on cytokine responsiveness of peripheral blood cells. J Immunol, 2010;184(12) :7297 -7304.
  • 6Irons RD, Le AT. Dithiocarbamates and viral IL-10 collaborate in the immortalization and evasion of immune response in EBV infected human B lymphocytes. Chem Biol Interact,2008 ;172 ( 1 ) : 81 -92.
  • 7Leao M, Anderton E, Wade M, et aL Epstein-Barr virus-induced resistance to drugs that activate the mitotic spindle assembly checkpoint in Burkitt's lymphoma cells. J Virol,2007 ; 81 ( 1 ) 248 - 260.
  • 8Jarrett RF, Krajewski AS, Angus B, et al. The Scotland and Newcastle epidemiological study of Hodgkin's disease: impact of histopathological review and EBV status on incidence estimates. J Clin Pathol,2003 ;56( 11 ) :811 -816.
  • 9Glaser SL, Gulley ML, larke CA, et al. Racial/ethnic variation in EBV-positive classical Hodgkin lymphoma in California popu- lations. Int J Cancer,2008; 123(7) : 1499 -1507.
  • 10卢愿,孙立荣,庞秀英,吕振华,隋爱华,李学荣,宋爱琴.EB病毒在儿童白血病患者中的感染状况及其临床意义——附35例报告[J].癌症,2007,26(1):54-57. 被引量:3

二级参考文献11

  • 1Telenti A, Marshall W F, Smith T F. Detection of Epstein-Barr virus by polymerase chain reaction [J]. J Clin Microbiol,1990,28(10) :2187-2190.
  • 2Young L S, Rickinson A B. Epstein-Barr virus: 40 years on[J]. Nat Rev Cancer, 2004,4(10):757-768.
  • 3Rickinson A B, Lee S P, Steven N M. Cytotoxic T lymphocyte responses to Epstein-Barr virus [J]. Curt Opin Immunol, 1996,8 (4) : 492-497.
  • 4Grogan E, Jenson H, Countryman J, et al. Transfection of a rearranged viral DNA fragment, Wzhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells [J]. Proc Natl Acad Sci USA, 1987,84(5):1332-1336.
  • 5Desjardin L E, Chen Y, Perkins M D, et al. Comparison of the ABI7700 system (TaqMan) and competitive PCR for quantification of IS6110 DNA in sputum during treatment of tuberculosis [J]. J Clin Microbil, 1998,36(7) : 1964-1968.
  • 6Nemerow G R, Mold C, Schwend V K, et al. Identification of gp350 as the viral glyeoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d[J]. J Virol, 1987,61(5):1416-1420.
  • 7Ishikura H, Matsuno Y, Okano M, et al. A Japanese Burkitt's lymphoma with t(2;8) and EBNA [J]. Acta Pathol Jpn, 1986,36( 1 ) : 133-142.
  • 8Grimm T, Schneider S, Naschberger E, et al. EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX [ J ]. Blood, 2005,105 (8) : 3263-3269.
  • 9Niller H H, Salamon D, Ilg K, et al. The in vivo binding site for oneoprotein c-Myc in the promoter for Epstein-Barr virus(EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesis [J]. Med Sci Monit, 2003,9(1) :HY1-9.
  • 10顾龙君,孙桂香,卢新天,汤静燕,吴敏媛.小儿急性淋巴细胞白血病诊疗建议(第二次修订草案)[J].中华儿科杂志,1999,37(5):305-307. 被引量:304

共引文献2

同被引文献88

引证文献6

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部